Benzinga | Apr 21, 2021 08:43AM EDT

Morgan Stanley Maintains Overweight on Edwards Lifesciences, Raises Price Target to $108

Morgan Stanley maintains Edwards Lifesciences (NYSE:EW) with a Overweight and raises the price target from $99 to $108.